Disclosed are compounds of the Formula I
and pharmaceutically acceptable salts and prodrugs thereof, wherein R
1
, R
2
, R
7
, R
8
, R
9
and R
10
, W and Y are as defined in the specification. Such compounds are MEK inhibitors and useful in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals. Also disclosed are methods of using such compounds in the treatment of hyperproliferative diseases in mammals and pharmaceutical compositions containing such compounds.
本发明涉及具有式I的化合物及其药用可接受的盐和前药,其中R1、R2、R7、R8、R9和R10、W和Y如规范中所定义。这些化合物是MEK
抑制剂,在哺乳动物中用于治疗高增殖性疾病,如癌症和炎症。还公开了在哺乳动物中使用这些化合物治疗高增殖性疾病的方法以及含有这些化合物的药物组合物。